Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Czechia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20071
20081
20091
20111
20142
20162
20174
20181
20191
20201
20212
20221
20231
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting6
Active, not recruiting5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
AstraZeneca3
Amgen2
Bristol-Myers Squibb2
GlaxoSmithKline2
Hoffmann-La Roche2
Boehringer Ingelheim1
Celgene1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma29
Lung Neoplasms4
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Anus Neoplasms1
Biliary Tract Neoplasms1
Carcinoma1
Carcinoma, Hepatocellular1
Carcinoma, Merkel Cell1
Carcinoma, Renal Cell1

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.